Market Analysis
Earnings Review: Medtronic Beats Expectations with 6% Increase in Revenue
Medtronic reported an EPS of $1.2, beating the expected $1.18. The firm's revenue grew by 6% in Q2 FY24.
BTC$65,943.00-0.42%
ETH$1,932.88+0.77%
USDT$0.9994+0.01%
USDC$1.+0.01%
XRP$1.14-0.30%
SOL$77.75-0.13%
TRX$0.3285-0.16%
FIGR_HELOC$1.01+0.34%
HYPE$58.90-3.16%
DOGE$0.0728-0.40%
RAIN$0.0143-5.11%
USDS$0.99990.00%
LEO$9.69-0.25%
ZEC$512.09-3.82%
WBT$57.51-0.20%
BTC$65,943.00-0.42%
ETH$1,932.88+0.77%
USDT$0.9994+0.01%
USDC$1.+0.01%
XRP$1.14-0.30%
SOL$77.75-0.13%
TRX$0.3285-0.16%
FIGR_HELOC$1.01+0.34%
HYPE$58.90-3.16%
DOGE$0.0728-0.40%
RAIN$0.0143-5.11%
USDS$0.99990.00%
LEO$9.69-0.25%
ZEC$512.09-3.82%
WBT$57.51-0.20%
Medtronic's fourth-quarter performance exceeded expectations, with notable growth in key segments.
Medtronic reported an EPS of $1.2, beating the expected $1.18. The firm's revenue grew by 6% in Q2 FY24.